Schellenberg, J. J., Adam, H. J., Baxter, M. R., Karlowsky, J. A., & Zhanel, G. G. (2026). 'Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018–2021-right-to-reply'. Journal of Antimicrobial Chemotherapy (JAC), 81(4), 1. https://doi.org/10.1093/jac/dkag126
Chicago Style (17th ed.) CitationSchellenberg, John J., Heather J. Adam, Melanie R. Baxter, James A. Karlowsky, and George G. Zhanel. "'Comparing Serotype Coverage of Pneumococcal Vaccines with PCV21 (V116), a New 21-valent Conjugate Pneumococcal Vaccine, and the Epidemiology of Its Eight Unique Streptococcus Pneumoniae Serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) Causing Invasive Pneumococcal Disease in Adult Patients in Canada: SAVE Study, 2018–2021-right-to-reply'." Journal of Antimicrobial Chemotherapy (JAC) 81, no. 4 (2026): 1. https://doi.org/10.1093/jac/dkag126.
MLA (9th ed.) CitationSchellenberg, John J., et al. "'Comparing Serotype Coverage of Pneumococcal Vaccines with PCV21 (V116), a New 21-valent Conjugate Pneumococcal Vaccine, and the Epidemiology of Its Eight Unique Streptococcus Pneumoniae Serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) Causing Invasive Pneumococcal Disease in Adult Patients in Canada: SAVE Study, 2018–2021-right-to-reply'." Journal of Antimicrobial Chemotherapy (JAC), vol. 81, no. 4, 2026, p. 1, https://doi.org/10.1093/jac/dkag126.